Murthy L, Dreyer P, Suriyaarachchi P, Gomez F, Curcio C L, Boersma D, Duque G
Prof. Gustavo Duque, MD, Ph.D., FRACP, Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western health, 176 Furlong Road, St. Albans, VIC, Australia 3021, Tel: +61 3 8395 8121,Email:
J Frailty Aging. 2018;7(4):253-257. doi: 10.14283/10.14283/jfa.2018.22.
Frailty is associated with poor outcomes hence identification of risks factors is pivotal. Since the independent role of parathyroid hormone (PTH) in frailty remains unexplored, we aimed to determine this in a population of older individuals with a history of falling.
Cross-sectional study.
Falls and Fracture Clinic, Nepean Hospital (Penrith, Australia).
692 subjects (mean age=79, 65% women) assessed between 2009-2015.
Assessment included clinical examination, mood, nutrition, grip strength, gait velocity, bone densitometry and posturography. Chemistry included serum PTH, calcium, vitamin D (25(OH)D3), creatinine and albumin. Normocalcemic subjects were divided into 4 groups: (1) Normal: 25(OH)D3 >50nmol/L and PTH between 1.6-6.8pmol/L; (2) PTH responsive: low 25(OH)D3 (<50nmol/L) and high PTH (>6.8pmol/L); (3) PTH unresponsive: low 25(OH)D3 and normal PTH; (4) Hyper PTH (>6.8pmol/L) with normal 25(OH)D3. Frailty was defined using Fried's criteria. Difference between the groups was assessed using one-way ANOVA and X2 analysis. Multinomial logistic regression evaluated the association between the groups and the number of Fried's criteria adjusted for age, BMI, renal function, 25(OH)D3 levels, and albumin.
22.6% subjects had high PTH levels (>6.8pmol/L). All subjects in the high PTH groups had significantly lower grip strength, gait velocity, limits of stability, and higher BMI. The PTH responsive group had a higher risk of pre-frailty (β=3.8, 95% CI = 3.42 - 5.22, p≷ 0.01) and frailty (β=8.26, 95% CI = 2.8-16.1, p<0.01). The risk of frailty was also higher in the Hyper PTH group (β=2.3, 95% CI = 1.74-4.32, p<0.01).
We have reported an independent association of high PTH levels with high number of falls and with the clinical components of physical frailty in community dwelling older persons. Our results suggest a possible role of PTH in frailty that deserves further exploration.
衰弱与不良预后相关,因此识别风险因素至关重要。由于甲状旁腺激素(PTH)在衰弱中的独立作用尚未得到探索,我们旨在在有跌倒史的老年人群中确定这一点。
横断面研究。
澳大利亚彭里斯内佩恩医院跌倒与骨折诊所。
2009年至2015年期间评估的692名受试者(平均年龄 = 79岁,65%为女性)。
评估包括临床检查、情绪、营养、握力、步态速度、骨密度测定和姿势描记法。血液生化指标包括血清PTH、钙、维生素D(25(OH)D3)、肌酐和白蛋白。血钙正常的受试者分为4组:(1)正常组:25(OH)D3 > 50nmol/L且PTH在1.6 - 6.8pmol/L之间;(2)PTH反应性组:25(OH)D3低(< 50nmol/L)且PTH高(> 6.8pmol/L);(3)PTH无反应性组:25(OH)D3低且PTH正常;(4)25(OH)D3正常但PTH高(> 6.8pmol/L)组。衰弱采用弗里德标准定义。组间差异采用单因素方差分析和X²分析进行评估。多项逻辑回归评估了各组与根据年龄、体重指数、肾功能、25(OH)D3水平和白蛋白调整后的弗里德标准数量之间的关联。
22.6%的受试者PTH水平高(> 6.8pmol/L)。PTH高水平组的所有受试者握力、步态速度、稳定性极限均显著降低,且体重指数更高。PTH反应性组衰弱前期风险更高(β = 3.8,95%置信区间 = 3.42 - 5.22,p < 0.01),衰弱风险也更高(β = 8.26,95%置信区间 = 2.8 - 16.1,p < 0.01)。PTH高组的衰弱风险也更高(β = 2.3,95%置信区间 = 1.74 - 4.32,p < 0.01)。
我们报告了社区居住老年人中PTH高水平与跌倒次数多以及身体衰弱的临床指标之间存在独立关联。我们的结果表明PTH在衰弱中可能起作用,值得进一步探索。